Literature DB >> 25225430

Does toxicity predict efficacy? Insight into the mechanism of action of lapatinib.

Caterina Fontanella1, Bianca Lederer2, Valentina Nekljudova2, Michael Untch3, Gunter von Minckwitz2, Sibylle Loibl4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25225430     DOI： 10.1200/JCO.2014.57.0499

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Precision medicine for metastatic breast cancer--limitations and solutions.

Authors:  Monica Arnedos; Cecile Vicier; Sherene Loi; Celine Lefebvre; Stefan Michiels; Herve Bonnefoi; Fabrice Andre
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

Review 2.  'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.

Authors:  Sabba Mehmood; Muhammad Faheem; Hammad Ismail; Syeda Mehpara Farhat; Mahwish Ali; Sidra Younis; Muhammad Nadeem Asghar
Journal:  Front Mol Biosci       Date:  2022-04-14

3.  Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study.

Authors:  Ze Yu; Xuan Ye; Hongyue Liu; Huan Li; Xin Hao; Jinyuan Zhang; Fang Kou; Zeyuan Wang; Hai Wei; Fei Gao; Qing Zhai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

4.  Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Authors:  Amir Sonnenblick; Evandro de Azambuja; Dominique Agbor-Tarh; Ian Bradbury; Christine Campbell; Yingjie Huang; Amylou C Dueck; Kathleen I Pritchard; Antonio C Wolff; Christian Jackisch; Istvan Lang; Michael Untch; Ian Smith; Frances Boyle; Binghe Xu; Henry Gomez; Edith A Perez; Martine Piccart; Hatem A Azim
Journal:  J Natl Cancer Inst       Date:  2016-04-20       Impact factor: 13.506

5.  Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.

Authors:  Moe Tsuda; Hiroshi Ishiguro; Naoko Toriguchi; Norikazu Masuda; Hiroko Bando; Masahiro Ohgami; Masato Homma; Satoshi Morita; Naohito Yamamoto; Katsumasa Kuroi; Yasuhiro Yanagita; Toshimi Takano; Satoru Shimizu; Masakazu Toi
Journal:  Cancer Med       Date:  2020-10-23       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.